Intellia Therapeutics, Inc. (11)

Browse by Contract Category

Contracts

Underwriting Agreement, dated as of December 1, 2020, by and among the Company and Goldman Sachs & Co LLC, Jefferies LLC, and SVB Leerink LLC, as representatives of the several... (Filed With SEC on December 2, 2020)
Corporate Bonus Plan, effective April 3, 2020 (Filed With SEC on August 6, 2020)
Amendment No. 1, dated May 30, 2020, to the License and Collaboration Agreement, dated April 11, 2016, by and between Intellia Therapeutics, Inc. and Regeneron Pharmaceuticals, Inc (Filed With SEC on June 1, 2020)
Lease, dated as of March 12, 2020, by and between the Company and 281-295 Albany Street Leasehold LLC (Filed With SEC on May 7, 2020)
Description of Certain Registrants Securities (Filed With SEC on February 27, 2020)
Agreement and Amendment to License and Collaborative Research Agreement, dated as of December 3, 2018, by and between Novartis and the Company (Filed With SEC on February 27, 2019)
Underwriting Agreement, dated as of June 2, 2020, by and among the Company and Goldman Sachs & Co. LLC, Jefferies LLC, and SVB Leerink LLC, as representatives of the several... (Filed With SEC on June 3, 2020)
Stock Purchase Agreement, dated May 30, 2020, by and between Intellia Therapeutics, Inc. and Regeneron Pharmaceuticals, Inc (Filed With SEC on June 1, 2020)
Second Amendment to Lease, dated as of March 12, 2020, by and between the Company and MIT 130 Brookline Leasehold LLC (Filed With SEC on May 7, 2020)
Second Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 27, 2020)
First Amendment to Lease, dated as of April 5, 2019, by and between the Company and MIT 130 Brookline Leasehold LLC (Filed With SEC on May 2, 2019)